CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed

Read the full 277 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE